Insights

Gathering insights about SLI…

Similar companies to SLI

SLI Tech Stack

SLI uses 8 technology products and services including Squarespace, Joomla, jQuery, and more. Explore SLI's tech stack below.

Squarespace
Content Management System
Joomla
Content Management System
jQuery
Javascript Libraries
jQuery Migrate
Javascript Libraries
PayPal
Payment Processing
reCAPTCHA
Security
Bootstrap
UI Frameworks
Apache
Web Servers

Media & News

Obesity market sales potential tightens as Novo and Lilly enter new era
The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is looking a lot less certain with U.S. prices falling for GLP-1 treatments from Novo Nordisk and Eli Lilly and competition heating up in the cash-pay consumer market.
Feb 02, 2026 | www.reuters.com
Eli Lilly: Obesity Pricing For Access Tradeoff A Net Positive
Eli Lilly enters 2026 with strong commercial momentum, pipeline wins, and shares near all-time highs. The company's strategic price cuts for Zepbound and commitment to a low-priced launch of orforglipron will secure Medicare coverage and expand the self-pay market. I expect the company to beat Q4 2025 revenue and EPS estimates next week and guide 2026 above current consensus numbers.
Jan 29, 2026 | seekingalpha.com
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today presented a poster titled "Investigating the Efficacy of Nimacimab Alone or in Combination with Tirzepatide, and as a Maintenance Therapy Post Tirzepatide Discontinuation in a Diet-Induced Obesity (DIO) Mouse Model" at Keystone's conference, Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects. Skye's presentation addressed the following questions regarding the ability of its peripherally-restricted CB1-inhibitor antibody: Can nimacimab enhance optimal and suboptimal doses of incretin agonists?
Jan 29, 2026 | www.globenewswire.com
New Clinical Data Demonstrate that VIVUS' QSYMIA® in Combination with Digitally Enhanced Lifestyle Interventions (DELI) Leads to Significantly Greater Reductions in Weight and Cardiovascular Risk Compared with DELI Alone in Adults with Obesity
— Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI alone — Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI alone
Jan 26, 2026 | www.globenewswire.com
iA Financial Group and the Fondation IUCPQ: Transforming Obesity Management and Total Wellbeing Through a Bold Partnership
QUEBEC CITY--(BUSINESS WIRE)--iA Financial Group announces a $200,000 donation to the Fondation IUCPQ. This funding will support the launch of the HARMONY research project, which aims to transform obesity management by combining medical treatment, nutritional guidance and customized physical activity. Obesity: a major public health challenge Obesity is a complex chronic disease that affects one in three adults (33%)1 and poses a major public health and total wellbeing challenge. It has far-reac.
Jan 21, 2026 | www.businesswire.com
Skye Bioscience to Present Poster at Keystone Obesity Conference
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will present a poster at Keystone's conference, Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects. Skye's presentation addresses the following questions regarding the ability of its peripherally-restricted CB1-inhibitor antibody: Can nimacimab enhance optimal and suboptimal doses of incretin agonists?
Jan 21, 2026 | www.globenewswire.com
CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.
Jan 12, 2026 | www.businesswire.com

SLI's Email Address Formats

SLI uses at least 2 format(s):

SLI Email Formats	Example	Percentage
FLast@shelteredliving.org	JDoe@shelteredliving.org	70%
First.Last@shelteredliving.org	John.Doe@shelteredliving.org	11%
FirstLast@shelteredliving.org	JohnDoe@shelteredliving.org	8%
F.Last@shelteredliving.org	J.Doe@shelteredliving.org	9%
FirLast@shelteredliving.org	JohDoe@shelteredliving.org	2%
FLast@slitopeka.org	JDoe@slitopeka.org	100%

Frequently Asked Questions

What is SLI's phone number?

You can contact SLI's main corporate office by phone at

+1-785-233-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SLI's stock symbol?

SLI is a publicly traded company; the company's stock symbol is SLIM.

What is SLI's official website and social media links?

SLI's official website is slitopeka.org and has social profiles on LinkedIn.

What is SLI's NAICS code?

SLI's NAICS code is 6241 - Individual and Family Services.

How many employees does SLI have currently?

As of January 2026, SLI has approximately 62 employees across 1 continents, including North America. Key team members include Chief Technology Officer: S. P.Chief Advancement And Community Engagement Officier: K. S.Vp Of Technology And Operations: K. B.. Explore SLI's employee directory with LeadIQ.

What industry does SLI belong to?

SLI operates in the Individual and Family Services industry.

What technology does SLI use?

SLI's tech stack includes SquarespaceJoomlajQueryjQuery MigratePayPalreCAPTCHABootstrapApache.

What is SLI's email format?

SLI's email format typically follows the pattern of FLast@shelteredliving.org. Find more SLI email formats with LeadIQ.

When was SLI founded?

SLI was founded in 1971.

SLI

Q: What is SLI's official website and social media links?

SLI's official website is slitopeka.org. SLI has social profiles on LinkedIn.

Q: How many employees does SLI have currently?

SLI has approximately 62 employees.

Q: What technology does SLI use?

SLI's tech stack includes TweenMax, MooTools, Google Fonts API, jQuery, PayPal.

Individual and Family ServicesKansas, United States51-200 Employees

A not-for-profit supporting the efforts of individuals living with intellectual/developmental disabilities by promoting: 
Success • Learning • Inclusion